MeSH D002032 - bulimia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Fluoxetine | Fluoxetine |  | 2002-01-31 |  |  |
| Olanzapine, Fluoxetine | Olanzapine Fluoxetine |  | 2012-06-19 |  |  | |
| Fluoxetine | Selfemra |  | 2014-02-03 |  |  | |
| Appco Pharma | Fluoxetine | Fluoxetine |  | 2018-11-21 |  |  |
| NATCO Pharma | Fluoxetine | Fluoxetine |  | 2008-11-17 |  |  |
| Lupin Research | Fluoxetine | Fluoxetine |  | 2019-02-08 |  |  |
| Sandoz | Fluoxetine | Fluoxetine |  | 2008-11-17 |  |  |
| Allergan | Fluoxetine | Sarafem |  | 2006-05-19 |  |  |
| Fluoxetine | Fluoxetine |  | 2002-01-29 |  |  | |
| Eli Lilly | Fluoxetine | Prozac |  | 1991-04-24 |  |  |
| Fluoxetine | Sarafem |  | 1987-12-29 |  |  | |
| Olanzapine, Fluoxetine | Symbyax |  | 2003-12-24 |  |  | |
| Aurobindo Pharma | Fluoxetine | Fluoxetine |  | 2008-01-31 |  |  |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/1
Phase 2
0%0/4
Phase 3
100%3/3
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use